Ordinary Adjustment | Solactive Global Vaccines and Infectious Diseases Index CNTR | Effective Date 14th May 2024
Solactive Global Vaccines and Infectious Diseases Index CNTR:
In the ordinary adjustment, the following composition will be implemented effective open 14th May 2024:
PFIZER INC |
BIONTECH SE |
MODERNA INC |
MERCK & CO. INC. |
SANOFI SA |
GSK PLC |
ASTRAZENECA PLC |
VIR BIOTECHNOLOGY INC |
VAXCYTE INC |
DYNAVAX TECHNOLOGIES CORP |
3SBIO INC |
ZOETIS INC |
IMMUNITYBIO INC |
ELI LILLY & CO |
GILEAD SCIENCES INC |
JOHNSON & JOHNSON |
MARAVAI LIFESCIENCES HOLDINGS INC |
WUXI BIOLOGICS CAYMAN INC |
REGENERON PHARMACEUTICALS |
ABBVIE INC |
SK BIOSCIENCE ORD |
LABORATORY CRP OF AMER HLDGS |
SHIONOGI & CO LTD ORD |
BAVARIAN NORDIC A/S |
BRISTOL-MYERS SQUIBB CO |
ADMA BIOLOGICS INC |
TG THERAPEUTICS INC |
CELLDEX THERAPEUTICS INC |
ABBOTT LABORATORIES |
DENKA CO LTD |